首页|改善间充质干细胞移植治疗肝硬化疗效方法的研究进展

改善间充质干细胞移植治疗肝硬化疗效方法的研究进展

扫码查看
间充质干细胞(mesenchymal stem cells,MSCs)作为一种新兴的治疗手段,在肝硬化治疗中展现出巨大潜力.为进一步提高MSC疗法在肝硬化治疗中的效果,本文综述了近年来的相关研究进展.通过检索PubMed和CNKI中国期刊全文数据库中的"肝硬化、肝纤维化、间充质干细胞、归巢、外泌体"等关键词,筛选了 2010 年至 2024 年间发表的文献,共纳入 36 篇与 MSCs治疗肝硬化相关的研究进行分析总结.研究表明,优化 MSCs的培养条件有助于有效维持细胞活力,并促进其大规模增殖和分化.此外,提高MSCs的归巢效率可以增加其在肝脏中的定植,从而增强肝硬化的治疗效果.通过调控或诱导 MSCs 相关的外泌体产生,并提高MSCs分泌组中细胞因子的活性,有望更有效地改善肝硬化的病理进程.这些策略为 MSCs在肝硬化治疗中的应用提供了新的研究方向和思路.
Research progress of methods to improve the efficacy of mesenchymal stem cells transplantation in the treatment of liver cirrhosis
Mesenchymal stem cells(MSCs)have emerged as a promising therapeutic strategy for the treatment of liver cirrhosis.To further enhance the therapeutic efficacy of MSC-based interventions in liver cirrhosis,this review sum-marized recent advancements in the field.A comprehensive literature search was conducted in the PubMed and CNKI databases using keywords such as liver cirrhosis,liver fibrosis,mesenchymal stem cells,homing and exosomes identifying 36 relevant studies published between 2010 and 2024 for analysis.Findings indicate that optimizing MSC cul-ture conditions is crucial for maintaining cell viability and promoting extensive proliferation and differentiation.Moreo-ver,enhancing MSC homing efficiency can increase hepatic engraftment,thereby improving therapeutic outcomes in liver cirrhosis.Modulating or inducing the production of MSC-derived exosomes,as well as enhancing the bioactivity of cyto-kines within the MSC secrete,holds potential for effectively mitigating the pathological progression of liver cirrhosis.These strategies offer novel insights and avenues for advancing the application of MSCs in the treatment of liver cirrhosis.

Liver cirrhosisMesenchymal stem cellsEfficacyHomingExosomes

熊芷玉、江应安

展开 >

武汉大学人民医院感染科,湖北 武汉 430000

肝硬化 间充质干细胞 疗效 归巢 外泌体

武汉大学抗衰老研究中心教育发展基金会

2002330

2024

胃肠病学和肝病学杂志
郑州大学

胃肠病学和肝病学杂志

CSTPCD
影响因子:1.029
ISSN:1006-5709
年,卷(期):2024.33(10)
  • 2